Heart failure (HF) societies around the world have agreed on the following new universal definition of HF: “a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion.” They have also proposed a revised … [Read more...] about Heart failure classification according to ejection fraction
Heart failure
Top 10 Highlights of ESC Congress 2021
The European Society of Cardiology (ESC) 2021 occurred virtually this year from 27-30 August. Here is our curated list of the top 10 highlights of ESC 2021. EMPEROR-Preserved trial1 (NCT03057951): This phase 3 trial randomized 5988 adults with chronic heart failure (HF) with preserved ejection fraction (HFpEF) to take either sodium-glucose cotransporter 2 inhibitor … [Read more...] about Top 10 Highlights of ESC Congress 2021
Longer working hours increase risk of secondary coronary events
The International Labour Office reports that approximately 20% of workers worldwide work >48 hours per week. Research suggests an association between long working hours and incident coronary heart disease (CHD) events. No studies have explored if the same association exists between long working hours and subsequent CHD events. Prof. Xavier Trudel and his team conducted a … [Read more...] about Longer working hours increase risk of secondary coronary events
COVID-19 in adults with congenital heart disease
Heart disease was identified as a risk factor for mortality early in the COVID-19 pandemic. It was unknown if this risk would also apply to patients with congenital heart disease (CHD). To assess this risk, researchers conducted an international, multicenter retrospective study on 1044 patients with CHD who had been diagnosed with COVID-19. Infection was confirmed by … [Read more...] about COVID-19 in adults with congenital heart disease
Top 10 Highlights of ACC 2021
The American College of Cardiology (ACC) 2021 scientific sessions took place virtually this year from 15-17 May. Here is our curated list of the top 10 highlights of these sessions. TALOS-AMI trial1: This trial followed 2697 patients who had experienced myocardial infarction (MI), undergone percutaneous coronary intervention (PCI), and completed 1 month of dual … [Read more...] about Top 10 Highlights of ACC 2021